美国对进口药物征收关税以促进国内制造业. US imposes tariffs on imported drugs to boost domestic manufacturing.

美国政府计划对进口的专利品牌药物征收高达100%的关税, 以使制造业回归国内并降低价格. The U.S. government plans to impose tariffs of up to 100% on imported, patented brand-name drugs to bring manufacturing back home and lower prices. 对于投资美国产品或同意降低价格的公司,关税将较低或为零. Tariffs would be lower or zero for companies that invest in U.S. production or agree to lower prices. 该政策针对来自欧盟,日本,韩国,瑞士和英国的药物,实施时间为120至180天. The policy targets medicines from the EU, Japan, South Korea, Switzerland, and the UK, with implementation set for 120 to 180 days. 批评人士警告说,关税可能会增加成本并破坏该行业最近的投资. Critics warn the tariffs could raise costs and disrupt recent investments in the sector.